Unlike skin melanomas, BRAF mutations are extremely rare in uveal melanomas, where the vast majority show mutations in the genes GNAQ and GNA11 [109,110] that activate the mitogen-activated protein kinase (MAPK) pathway and, consequently, result in increased cell proliferation. The gene discussed is WNK2; the disease is cutaneous melanoma.